Replies to post #93774 on Biotech Values

[DewDiligence]

NVS expects the FDA to delay its Gilenia (FTY720) decision past the PDUFA date in June because there are only a few days between the advisory panel on 6/10/10 and the PDUFA date. (Source: Today’s NVS CC)